These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 20078897)

  • 21. The role of active case finding in reducing patient incurred catastrophic costs for tuberculosis in Nepal.
    Gurung SC; Dixit K; Rai B; Caws M; Paudel PR; Dhital R; Acharya S; Budhathoki G; Malla D; Levy JW; van Rest J; Lönnroth K; Viney K; Ramsay A; Wingfield T; Basnyat B; Thapa A; Squire B; Wang D; Mishra G; Shah K; Shrestha A; de Siqueira-Filha NT
    Infect Dis Poverty; 2019 Dec; 8(1):99. PubMed ID: 31791412
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Measuring the economic burden for TB patients in the End TB Strategy and Universal Health Coverage frameworks.
    Pedrazzoli D; Borghi J; Viney K; Houben RMGJ; Lönnroth K
    Int J Tuberc Lung Dis; 2019 Jan; 23(1):5-11. PubMed ID: 30674374
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparing disease specific catastrophic cost estimates using longitudinal and cross-sectional designs: The example of tuberculosis.
    Yamanaka T; Castro MC; Ferrer JP; Cox SE; Laurence YV; Vassall A
    Soc Sci Med; 2024 Mar; 344():116631. PubMed ID: 38308959
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The economic burden of tuberculosis care for patients and households in Africa: a systematic review.
    Ukwaja KN; Modebe O; Igwenyi C; Alobu I
    Int J Tuberc Lung Dis; 2012 Jun; 16(6):733-9. PubMed ID: 22410546
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tuberculosis and poverty: the contribution of patient costs in sub-Saharan Africa--a systematic review.
    Barter DM; Agboola SO; Murray MB; Bärnighausen T
    BMC Public Health; 2012 Nov; 12():980. PubMed ID: 23150901
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Financial burden for tuberculosis patients in low- and middle-income countries: a systematic review.
    Tanimura T; Jaramillo E; Weil D; Raviglione M; Lönnroth K
    Eur Respir J; 2014 Jun; 43(6):1763-75. PubMed ID: 24525439
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patients are paying too much for tuberculosis: a direct cost-burden evaluation in Burkina Faso.
    Laokri S; Drabo MK; Weil O; Kafando B; Dembélé SM; Dujardin B
    PLoS One; 2013; 8(2):e56752. PubMed ID: 23451079
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The economic effects of supporting tuberculosis-affected households in Peru.
    Wingfield T; Tovar MA; Huff D; Boccia D; Montoya R; Ramos E; Lewis JJ; Gilman RH; Evans CA
    Eur Respir J; 2016 Nov; 48(5):1396-1410. PubMed ID: 27660507
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The economic burden of TB-affected households in DR Congo.
    Kaswa M; Minga G; Nkiere N; Mingiedi B; Eloko G; Nguhiu P; Baena IG
    Int J Tuberc Lung Dis; 2021 Nov; 25(11):923-932. PubMed ID: 34686235
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Examining Approaches to Estimate the Prevalence of Catastrophic Costs Due to Tuberculosis from Small-Scale Studies in South Africa.
    Sweeney S; Vassall A; Guinness L; Siapka M; Chimbindi N; Mudzengi D; Gomez GB
    Pharmacoeconomics; 2020 Jun; 38(6):619-631. PubMed ID: 32239479
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The economic burden of illness for households in developing countries: a review of studies focusing on malaria, tuberculosis, and human immunodeficiency virus/acquired immunodeficiency syndrome.
    Russell S
    Am J Trop Med Hyg; 2004 Aug; 71(2 Suppl):147-55. PubMed ID: 15331831
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The socioeconomic impact of multidrug resistant tuberculosis on patients: results from Ethiopia, Indonesia and Kazakhstan.
    van den Hof S; Collins D; Hafidz F; Beyene D; Tursynbayeva A; Tiemersma E
    BMC Infect Dis; 2016 Sep; 16(1):470. PubMed ID: 27595779
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A 2020 baseline assessment for the monitoring of the End TB indicator of catastrophic costs in Burkina Faso.
    Diallo A; Combary A; Bakyono R; Guene H; Ouedraogo S; Garcia Baena I; Moyenga L; Berthe A; Dahourou DL; Nguhiu P; Laokri S
    Int J Tuberc Lung Dis; 2022 Oct; 26(10):970-977. PubMed ID: 36163665
    [No Abstract]   [Full Text] [Related]  

  • 34. Socio-protective effects of active case finding on catastrophic costs from tuberculosis in Ho Chi Minh City, Viet Nam: a longitudinal patient cost survey.
    Vo LNQ; Forse RJ; Codlin AJ; Dang HM; Van Truong V; Nguyen LH; Nguyen HB; Nguyen NV; Sidney-Annerstedt K; Lonnroth K; Squire SB; Caws M; Worrall E; de Siqueira-Filha NT
    BMC Health Serv Res; 2021 Oct; 21(1):1051. PubMed ID: 34610841
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cost-effectiveness of different treatment strategies for tuberculosis in Egypt and Syria.
    Vassall A; Bagdadi S; Bashour H; Zaher H; Maaren PV
    Int J Tuberc Lung Dis; 2002 Dec; 6(12):1083-90. PubMed ID: 12546116
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Illness costs to households are a key barrier to access diagnostic and treatment services for tuberculosis in Tajikistan.
    Ayé R; Wyss K; Abdualimova H; Saidaliev S
    BMC Res Notes; 2010 Dec; 3():340. PubMed ID: 21172015
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of financial support on reducing the incidence of catastrophic costs among tuberculosis-affected households in Indonesia: eight simulated scenarios.
    Fuady A; Houweling TAJ; Mansyur M; Burhan E; Richardus JH
    Infect Dis Poverty; 2019 Feb; 8(1):10. PubMed ID: 30709415
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Measuring catastrophic costs due to tuberculosis in Viet Nam.
    Nhung NV; Hoa NB; Anh NT; Anh LTN; Siroka A; Lönnroth K; Garcia Baena I
    Int J Tuberc Lung Dis; 2018 Sep; 22(9):983-990. PubMed ID: 30092862
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Economic evaluation of public-private mix for tuberculosis care and control, India. Part I. Socio-economic profile and costs among tuberculosis patients.
    Pantoja A; Floyd K; Unnikrishnan KP; Jitendra R; Padma MR; Lal SS; Uplekar M; Chauhan LS; Kumar P; Sahu S; Wares F; Lönnroth K
    Int J Tuberc Lung Dis; 2009 Jun; 13(6):698-704. PubMed ID: 19460244
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.